{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:32:08Z","timestamp":1761489128995},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.ijrobp.2013.01.034","type":"journal-article","created":{"date-parts":[[2013,4,16]],"date-time":"2013-04-16T12:48:50Z","timestamp":1366116530000},"page":"8-10","source":"Crossref","is-referenced-by-count":11,"title":["RTOG 0529: Intensity Modulated Radiation Therapy and Anal Cancer, a Step in the Right Direction?"],"prefix":"10.1016","volume":"86","author":[{"given":"Joseph M.","family":"Herman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Charles R.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2013.01.034_bib1","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.currproblcancer.2009.10.003","article-title":"Anal cancer: Progress on combined-modality and organ preservation","volume":"33","author":"Chan","year":"2009","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.ijrobp.2013.01.034_bib2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.6004\/jnccn.2012.0046","article-title":"Anal carcinoma, version 2.2012: Featured updates to the NCCN guidelines","volume":"10","author":"Benson","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ijrobp.2013.01.034_bib3","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: A randomized controlled trial","volume":"299","author":"Ajani","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2013.01.034_bib4","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","article-title":"Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: Survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin","volume":"30","author":"Gunderson","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2013.01.034_bib5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1586\/14737140.8.4.585","article-title":"Emerging role of intensity-modulated radiation therapy in anorectal cancer","volume":"8","author":"Meyer","year":"2008","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.ijrobp.2013.01.034_bib6","first-page":"828, 830","article-title":"Intensity-modulated radiation therapy for anal cancer: An obvious yet complicated transition","volume":"24","author":"Herman","year":"2010","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.ijrobp.2013.01.034_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1748-717X-2-41","article-title":"Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: A comparison of conventional and IMRT plans","volume":"2","author":"Menkarios","year":"2007","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2013.01.034_bib8","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1002\/cncr.25901","article-title":"Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal","volume":"117","author":"Bazan","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2013.01.034_bib9","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.ijrobp.2009.09.046","article-title":"Intensity-modulated radiation therapy for anal malignancies: A preliminary toxicity and disease outcomes analysis","volume":"78","author":"Pepek","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.01.034_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","article-title":"RTOG 0529: A phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal","volume":"86","author":"Kachnic","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.01.034_bib11","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.08.070","article-title":"Elective clinical target volumes for conformal therapy in anorectal cancer: A radiation therapy oncology group consensus panel contouring atlas","volume":"74","author":"Myerson","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.01.034_bib12","doi-asserted-by":"crossref","first-page":"821","DOI":"10.6004\/jnccn.2011.0071","article-title":"Proton therapy in an era of cost containment","volume":"9","author":"Herman","year":"2011","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ijrobp.2013.01.034_bib13","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/cncr.26365","article-title":"Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer","volume":"118","author":"Murphy","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2013.01.034_bib14","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/COC.0b013e31826e0515","article-title":"American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) practice guideline for intensity-modulated radiation therapy (IMRT)","volume":"35","author":"Hartford","year":"2012","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2013.01.034_bib15","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1200\/JCO.2011.36.7136","article-title":"Updated analysis of SWOG-directed intergroup study 0116: A phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection","volume":"30","author":"Smalley","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2013.01.034_bib16","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1245\/s10434-011-1630-6","article-title":"Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup\/RTOG 9704 phase III trial","volume":"18","author":"Regine","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2013.01.034_bib17","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1016\/j.ijrobp.2012.01.023","article-title":"Pelvic normal tissue contouring guidelines for radiation therapy: A radiation therapy oncology group consensus panel atlas","volume":"83","author":"Gay","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.01.034_bib18","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ijrobp.2011.12.058","article-title":"Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer","volume":"83","author":"Ng","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.01.034_bib19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ijrobp.2009.11.012","article-title":"Prospective randomized double-blind pilot study of site-specific consensus atlas implementation for rectal cancer target volume delineation in the cooperative group setting","volume":"79","author":"Fuller","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.01.034_bib20","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ijrobp.2009.10.054","article-title":"Teaching the anatomy of oncology: Evaluating the impact of a dedicated oncoanatomy course","volume":"79","author":"Chino","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.01.034_bib21","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ijrobp.2008.04.028","article-title":"Head-and-neck target delineation among radiation oncology residents after a teaching intervention: A prospective, blinded pilot study","volume":"73","author":"Bekelman","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.01.034_bib22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijrobp.2011.10.068","article-title":"Setup variations in radiotherapy of anal cancer: Advantages of target volume reduction using image-guided radiation treatment","volume":"84","author":"Chen","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.01.034_bib23","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.ijrobp.2011.05.027","article-title":"Radiation therapy oncology group 0247: A randomized phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer","volume":"82","author":"Wong","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.01.034_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/cncr.20336","article-title":"Circulating D-dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastatic colorectal carcinoma","volume":"101","author":"Blackwell","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2013.01.034_bib25","article-title":"Feasibility and value of PatientViewpoint: A web system for patient-reported outcomes assessment in clinical practice","author":"Snyder","year":"2012","journal-title":"Psychooncology"},{"key":"10.1016\/j.ijrobp.2013.01.034_bib26","first-page":"45","article-title":"Longitudinal quality-of-life analysis of RTOG 94-05 (int 0123): A phase III trial of definitive chemoradiotherapy for esophageal cancer","volume":"4","author":"Kachnic","year":"2011","journal-title":"Gastrointest Cancer Res"},{"key":"10.1016\/j.ijrobp.2013.01.034_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1200\/JCO.2012.46.4891","article-title":"Achieving the best of both worlds","volume":"31","author":"Ko","year":"2013","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301613001600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301613001600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T01:24:24Z","timestamp":1539739464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301613001600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0360301613001600"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2013.01.034","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}